Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bacterial Vaginosis
Researchers at La Sapienza University have published new data on bacterial vaginosis
May 1st, 2008
According to recent research published in the journal European Review for Medical and Pharmacological Sciences, "At the present the clinical treatment of choice of bacterial vaginosis (BV) is the use of systemic or local metronidazole or clindamycin. Aim of the study was to evaluate the efficacy and tolerability of a single dose of gynaecologic solution, Polyhexamethylene Biguanide (PHMB), Monogin(R), in the treatment of BV in comparison to a 7-days treatment with clindamycin vaginal cream." "This multicenter, randomized, single-blind, parallel-group study enrolled 740 patients with BV infections. Treatment consisted of either a single intravaginal dose of PHMB...
Source: Women's Health Weekly (2008-05-01)
|
